A client smokes 1.5 packs per day and wants to quit. Which approach is MOST evidence-based as first-line treatment?

Tobacco cessation is the single most impactful modifiable health behavior change for most smokers. EVIDENCE-BASED APPROACH: the 2008 USPHS Clinical Practice Guideline (updated) recommends COMBINATION of pharmacotherapy plus behavioral counseling as the most effective approach. PHARMACOTHERAPY OPTIONS: (1) NICOTINE REPLACEMENT THERAPY (NRT) — patches, gum, lozenge, inhaler, nasal spray; reduces withdrawal symptoms; multiple forms can be combined (e.g., patch for baseline + gum for cravings); available OTC and prescription; (2) VARENICLINE (Chantix) — prescription; partial nicotinic agonist; blocks nicotine's rewarding effects; most effective single pharmacotherapy; monitor for neuropsychiatric side effects; (3) BUPROPION (Zyban/Wellbutrin) — prescription antidepressant with nicotine receptor effects; can be used alone or combined with NRT. BEHAVIORAL COUNSELING: individual or group; motivational interviewing; quit-smoking programs; quit lines (1-800-QUIT-NOW national helpline — free). THE 5 A's FRAMEWORK for brief intervention: ASK (about tobacco use at every visit); ADVISE (urge to quit in a clear, personalized, strong way); ASSESS (readiness to quit); ASSIST (offer pharmacotherapy, counseling, referral); ARRANGE (follow-up to check on progress). E-CIGARETTES are not FDA-approved cessation devices and evidence for their effectiveness as cessation tools is insufficient; they carry their own health risks. Simply reducing cigarette count ('cutting down') without a quit plan usually doesn't lead to lasting cessation. PN ROLE: ask about tobacco use at every visit; advise to quit; provide brief counseling; refer to cessation resources; acknowledge that quit attempts are often required multiple times before success.